US biotech AeroRx Therapeutics has secured $21 million in Series A financing to advance its lead program, AERO-007, into ...

Dutch biotech uniQure recently announced that its novel gene therapy, AMT-130 (ifezuntirgene inilparvovec), demonstrated ...

UK-based developer of novel immunoglobulin E (IgE) antibodies to treat cancer, Epsilogen, today announced the appointment of ...

The atrial fibrillation (AF) market across the eight major markets (8MM) is forecast to decline at a negative compound annual ...

Australian biotech Neurizon Therapeutics (ASX: NUZ) said the US regulator has lifted the clinical hold on its lead drug ...

Skye Bioscience (Nasdaq: SKYE) reported topline data from a mid-stage trial showing that its obesity drug nimacimab failed to ...

Belgian biotech Bioxodes has appointed Philippe Monteyne as chairman of its board, replacing Pierre Detrixhe. The move comes ...

US lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that member companies, thanks to ...

Oxford, UK-based clinical-stage biotech Theolytics today announced the appointment of Dr Matilde Saggese, as chief medical ...

UK pharma major AstraZeneca has entered into a multi-target partnership with Algen Biotechnologies, the California, USA biotech announced.

Italian biotech NanoPhoria Bioscience has announced the successful first close of its 83.5 million euros ($97.4 million) Series A financing round.

UK-based Trogenix, a biotech founded by VC firm 4BIO Capital developing innovative cancer therapies, has secured a £70 ...